Related Experiment Video
Updated: May 4, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Frequency of chromosomally-integrated human herpesvirus 6 in children with acute lymphoblastic leukemia
Annie Gravel1, Daniel Sinnett2, Louis Flamand3
1Division of Infectious Diseases and Immunity, CHU de Quebec Research Center, Quebec, Canada.
Insights
Chromosomally-integrated Human Herpesvirus 6 (ciHHV-6) was investigated in children with acute lymphoblastic leukemia. The study found no significant difference in ciHHV-6 frequency between leukemia patients and healthy donors, suggesting it does not cause leukemia.
Area of Science:
- Virology
- Oncology
- Genetics
Background:
- Human herpesvirus 6 (HHV-6) is a common virus, with 0.2-1% of infected individuals carrying chromosomally-integrated HHV-6 (ciHHV-6).
- The biological impact of ciHHV-6 remains largely unknown.
Purpose of the Study:
- To compare the prevalence of ciHHV-6 in pediatric acute lymphoblastic leukemia (ALL) patients versus healthy controls.
- To investigate the potential link between ciHHV-6 and ALL development.
Main Methods:
- Quantitative TaqMan PCR (QPCR) was used to detect ciHHV-6 DNA in 293 children with ALL and 288 healthy individuals.
- HHV-6 specific primers and probes were employed, with GAPDH primers used for DNA quality control.
Main Results:
- One case (0.35%) of ciHHV-6 (variant A) was detected in the ALL cohort.
- No ciHHV-6 was found in the 288 healthy control samples.
- The frequency of ciHHV-6 was statistically similar between the ALL and control groups (p=0.5).
Conclusions:
- The prevalence of ciHHV-6 is comparable in children with ALL and healthy individuals.
- These findings indicate that ALL does not appear to arise as a consequence of HHV-6 chromosomal integration.
- Further research is needed to fully understand the biological consequences of ciHHV-6.
Introduction:
Human herpesvirus 6 (HHV-6) is a ubiquitous pathogen infecting nearly 100% of the human population. Of these individuals, between 0.2% and 1% of them carry chromosomally-integrated HHV-6 (ciHHV-6). The biological consequences of chromosomal integration by HHV-6 remain unknown.
Objective:
To determine and compare the frequency of ciHHV-6 in children with acute lymphoblastic leukemia to healthy blood donors.
Methodology:
A total of 293 DNA samples from children with pre-B (n=255), pre-pre-B (n=4), pre-T (n=26) and undetermined (n=8) leukemia were analyzed for ciHHV-6 by quantitative TaqMan PCR (QPCR) using HHV-6 specific primers and probe. As control, DNA samples from 288 healthy individuals were used. Primers and probe specific to the cellular GAPDH gene were used to estimate integrity and DNA content.
Results:
Out of 293 DNA samples from the leukemic cohort, 287 contained amplifiable DNA. Of these, only 1 (0.35%) contained ciHHV-6. Variant typing indicates that the ci-HHV-6 corresponds to variant A. None of the 288 DNA samples from healthy individuals contained ciHHV-6.
Conclusion:
The frequency of ciHHV-6 in children with acute lymphoblastic leukemia is similar (p=0.5) to that of healthy individuals. These results suggest that acute lymphoblastic leukemia does not originate as a consequence to integration of HHV-6 within the chromosomes.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

